Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer

Background: The incidence of thyroid cancer in women is 3–4-fold higher than in men. To characterize sex-specific molecular alterations in thyroid cancer, we examined the expression of sex-biased genes in normal thyroids and thyroid tumors. Methods: Ingenuity pathways analysis was used to define sex...

Full description

Bibliographic Details
Main Authors: Leila Shobab, Hui Zheng, Kirk Jensen, Maria Cecilia Mendonca-Torres, Matthew McCoy, Victoria Hoperia, Jennifer Rosen, Leonard Wartofsky, Kenneth Burman, Vasyl Vasko
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/16/7/1260
_version_ 1797212884424458240
author Leila Shobab
Hui Zheng
Kirk Jensen
Maria Cecilia Mendonca-Torres
Matthew McCoy
Victoria Hoperia
Jennifer Rosen
Leonard Wartofsky
Kenneth Burman
Vasyl Vasko
author_facet Leila Shobab
Hui Zheng
Kirk Jensen
Maria Cecilia Mendonca-Torres
Matthew McCoy
Victoria Hoperia
Jennifer Rosen
Leonard Wartofsky
Kenneth Burman
Vasyl Vasko
author_sort Leila Shobab
collection DOAJ
description Background: The incidence of thyroid cancer in women is 3–4-fold higher than in men. To characterize sex-specific molecular alterations in thyroid cancer, we examined the expression of sex-biased genes in normal thyroids and thyroid tumors. Methods: Ingenuity pathways analysis was used to define sex-biased gene networks using data from the Cancer Genome Atlas (TCGA). Confirmatory studies were performed through the analysis of histone lysine demethylases (KDMs) expression by real-time PCR and immunostaining. Results: In normal thyroids, 44 sex-biased genes were comparatively upregulated in male and 28 in female patients. The expressions of 37/72 (51%) sex-biased genes were affected in cancer tissues compared with normal thyroids. Gene network analyses revealed sex-specific patterns in the expressions of KDM5C, KDM5D, and KDM6A. In confirmatory studies, KDM5D mRNA and protein were detected only in males, whereas KDM5C and KDM6A were detected in samples from male and female patients. Nuclear staining with anti-KDMs was found in normal thyroids, but a loss of nuclear expression with a concomitant gain of cytoplasmic staining was observed in cancer tissues. Conclusions: Normal thyroids have a sex-specific molecular signature, and the development of thyroid cancer is associated with a differential expression of sex-biased genes. The sex-specific expression of KDMs, coupled with cancer-related alterations in their intracellular localization, may contribute to mechanisms underlying sex differences in thyroid tumorigenesis.
first_indexed 2024-04-24T10:49:28Z
format Article
id doaj.art-f782d888d9324b1c92ef511dc9eaf859
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-04-24T10:49:28Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-f782d888d9324b1c92ef511dc9eaf8592024-04-12T13:15:52ZengMDPI AGCancers2072-66942024-03-01167126010.3390/cancers16071260Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid CancerLeila Shobab0Hui Zheng1Kirk Jensen2Maria Cecilia Mendonca-Torres3Matthew McCoy4Victoria Hoperia5Jennifer Rosen6Leonard Wartofsky7Kenneth Burman8Vasyl Vasko9Department of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USADepartment of Surgery, MedStar Washington Hospital Center, Washington, DC 20010, USADepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USADepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USAInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC 20007, USAInstitute of Biology and Medicine, Kyiv National University, 02000 Kyiv, UkraineDepartment of Surgery, MedStar Washington Hospital Center, Washington, DC 20010, USADepartment of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USADepartment of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USADepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USABackground: The incidence of thyroid cancer in women is 3–4-fold higher than in men. To characterize sex-specific molecular alterations in thyroid cancer, we examined the expression of sex-biased genes in normal thyroids and thyroid tumors. Methods: Ingenuity pathways analysis was used to define sex-biased gene networks using data from the Cancer Genome Atlas (TCGA). Confirmatory studies were performed through the analysis of histone lysine demethylases (KDMs) expression by real-time PCR and immunostaining. Results: In normal thyroids, 44 sex-biased genes were comparatively upregulated in male and 28 in female patients. The expressions of 37/72 (51%) sex-biased genes were affected in cancer tissues compared with normal thyroids. Gene network analyses revealed sex-specific patterns in the expressions of KDM5C, KDM5D, and KDM6A. In confirmatory studies, KDM5D mRNA and protein were detected only in males, whereas KDM5C and KDM6A were detected in samples from male and female patients. Nuclear staining with anti-KDMs was found in normal thyroids, but a loss of nuclear expression with a concomitant gain of cytoplasmic staining was observed in cancer tissues. Conclusions: Normal thyroids have a sex-specific molecular signature, and the development of thyroid cancer is associated with a differential expression of sex-biased genes. The sex-specific expression of KDMs, coupled with cancer-related alterations in their intracellular localization, may contribute to mechanisms underlying sex differences in thyroid tumorigenesis.https://www.mdpi.com/2072-6694/16/7/1260thyroid cancersex differenceKDMshistone lysine demethylases
spellingShingle Leila Shobab
Hui Zheng
Kirk Jensen
Maria Cecilia Mendonca-Torres
Matthew McCoy
Victoria Hoperia
Jennifer Rosen
Leonard Wartofsky
Kenneth Burman
Vasyl Vasko
Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer
Cancers
thyroid cancer
sex difference
KDMs
histone lysine demethylases
title Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer
title_full Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer
title_fullStr Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer
title_full_unstemmed Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer
title_short Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer
title_sort sex specific expression of histone lysine demethylases kdms in thyroid cancer
topic thyroid cancer
sex difference
KDMs
histone lysine demethylases
url https://www.mdpi.com/2072-6694/16/7/1260
work_keys_str_mv AT leilashobab sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT huizheng sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT kirkjensen sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT mariaceciliamendoncatorres sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT matthewmccoy sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT victoriahoperia sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT jenniferrosen sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT leonardwartofsky sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT kennethburman sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer
AT vasylvasko sexspecificexpressionofhistonelysinedemethylaseskdmsinthyroidcancer